The approved reverse stock split and massive potential dilution from pre-funded warrants and convertible notes are critical for a $1M market cap stock. Monitor for the actual reverse split ratio and any subsequent share issuances, which could further pressure the stock. The CEO transition adds uncertainty to an already distressed micro-cap.
Price Chart
Executive Summary
CDT Equity Inc. appointed James Bligh as CEO, replacing Dr. Andrew Regan who resigned immediately. Bligh, who also remains CFO, receives a $600,000 base salary with a 50% target bonus. The annual meeting approved a reverse stock split (up to 1-for-500) and the issuance of up to 12.1M shares upon exercise of pre-funded warrants, signaling significant potential dilution for a micro-cap pharmaceutical company.
Key Facts
- James Bligh appointed CEO, replacing Dr. Andrew Regan who resigned immediately; Bligh also remains CFO until a successor is named.
- Bligh receives a $600,000 annual base salary and a target annual bonus of 50% of base salary.
- Dr. Regan receives a severance of $50,000/month for six months.
- Stockholders approved a reverse stock split at a ratio up to 1-for-500.
- Stockholders approved the issuance of up to 12,131,770 shares of common stock upon exercise of pre-funded warrants.
- Stockholders approved the issuance of shares under a senior secured convertible note and warrant issued to J.J. Astor & Co.
- The board was reduced from five to four members following Regan's resignation.
Financial Impact
CEO severance of $300,000 ($50k/mo x 6 months). Potential dilution from up to 12.1M pre-funded warrant shares and convertible note shares, significant relative to a $1M market cap.
Risk Factors
- Massive dilution from up to 12.1M pre-funded warrant shares and convertible note shares relative to a $1M market cap.
- Reverse stock split signals Nasdaq compliance risk and can further erode shareholder value.
- CEO transition at a micro-cap with no disclosed financials or pipeline progress.
- Historical model performance on CDT shows a 29% win rate at T+20, indicating high volatility and poor directional accuracy.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-040929 |
| Document: form8-k.htm | 0001493152-26-040929 |
| Document: 0001493152-26-040929-index-headers.html | 0001493152-26-040929 |
| Document: 0001493152-26-040929-index.html | 0001493152-26-040929 |
| Document: 0001493152-26-040929.txt | 0001493152-26-040929 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $37.00 $1.40 | ▲ +96.23% | ▲ +97.41% | $1.25 (+96.62%) |
Jul 31, 2026 9w ago | 8-K | $2.87 $1.68 | ▲ +41.36% | ▲ +42.60% | $1.25 (+56.37%) |
Jul 16, 2026 11w ago | 8-K | $0.3550 $3.15 | ▼ −785.92% | ▼ −782.30% | $1.25 (−252.11%) |
Jun 29, 2026 13w ago | 8-K | $0.5600 $2.85 | ▼ −408.04% | ▼ −409.06% | $1.25 (−123.21%) |
Jun 16, 2026 15w ago | 8-K | $0.6930 $0.3550 | ▲ +48.77% | ▲ +50.09% | $1.25 (−80.38%) |
May 6, 2026 21w ago | Press Release | $2.26 $0.8050 | ▼ −64.38% | ▼ −67.16% | $1.25 (−44.69%) |
Mar 4, 2026 30w ago | Press Release | $17.70 $5.10 | ▼ −71.19% | ▼ −66.77% | $1.25 (−92.94%) |
Feb 24, 2026 31w ago | 8-K | $17.25 $10.88 | ▼ −36.96% | ▼ −31.72% | $1.25 (−92.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access